These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34641962)

  • 1. Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma.
    Usyk M; Pandey A; Hayes RB; Moran U; Pavlick A; Osman I; Weber JS; Ahn J
    Genome Med; 2021 Oct; 13(1):160. PubMed ID: 34641962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients.
    Peters BA; Wilson M; Moran U; Pavlick A; Izsak A; Wechter T; Weber JS; Osman I; Ahn J
    Genome Med; 2019 Oct; 11(1):61. PubMed ID: 31597568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis.
    Yoshida N; Emoto T; Yamashita T; Watanabe H; Hayashi T; Tabata T; Hoshi N; Hatano N; Ozawa G; Sasaki N; Mizoguchi T; Amin HZ; Hirota Y; Ogawa W; Yamada T; Hirata KI
    Circulation; 2018 Nov; 138(22):2486-2498. PubMed ID: 30571343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome for predicting immune checkpoint blockade-associated adverse events.
    Hu M; Lin X; Sun T; Shao X; Huang X; Du W; Guo M; Zhu X; Zhou Y; Tong T; Guo F; Han T; Wu X; Shi Y; Xiao X; Zhang Y; Hong J; Chen H
    Genome Med; 2024 Jan; 16(1):16. PubMed ID: 38243343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
    Derosa L; Routy B; Fidelle M; Iebba V; Alla L; Pasolli E; Segata N; Desnoyer A; Pietrantonio F; Ferrere G; Fahrner JE; Le Chatellier E; Pons N; Galleron N; Roume H; Duong CPM; Mondragón L; Iribarren K; Bonvalet M; Terrisse S; Rauber C; Goubet AG; Daillère R; Lemaitre F; Reni A; Casu B; Alou MT; Alves Costa Silva C; Raoult D; Fizazi K; Escudier B; Kroemer G; Albiges L; Zitvogel L
    Eur Urol; 2020 Aug; 78(2):195-206. PubMed ID: 32376136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors.
    Zhang Y; Cheng S; Zou H; Han Z; Xie T; Zhang B; Dai D; Yin X; Liang Y; Kou Y; Tan Y; Shen L; Peng Z
    Front Cell Infect Microbiol; 2023; 13():1099063. PubMed ID: 37051296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxonomic and Functional Compositions of the Small Intestinal Microbiome in Neonatal Calves Provide a Framework for Understanding Early Life Gut Health.
    Malmuthuge N; Liang G; Griebel PJ; Guan LL
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30658973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy.
    Watson AS; Goutam S; Stukalin I; Ewanchuk BW; Sander M; Meyers DE; Pabani A; Cheung WY; Heng DYC; Cheng T; Monzon JG; Navani V
    JAMA Netw Open; 2022 Dec; 5(12):e2245596. PubMed ID: 36480204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unique composition of Indian gut microbiome, gene catalogue, and associated fecal metabolome deciphered using multi-omics approaches.
    Dhakan DB; Maji A; Sharma AK; Saxena R; Pulikkan J; Grace T; Gomez A; Scaria J; Amato KR; Sharma VK
    Gigascience; 2019 Mar; 8(3):. PubMed ID: 30698687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma: A Pooled Analysis.
    Mangla A; Lee C; Mirsky MM; Wang M; Rothermel LD; Hoehn R; Bordeaux JS; Carroll BT; Theuner J; Li S; Fu P; Kirkwood JM
    JAMA Oncol; 2024 May; 10(5):612-620. PubMed ID: 38546551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses.
    Chung YW; Gwak HJ; Moon S; Rho M; Ryu JH
    PLoS One; 2020; 15(1):e0227886. PubMed ID: 31978162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade.
    Chen S; McMiller TL; Soni A; Succaria F; Sidhom JW; Cappelli LC; Casciola-Rosen LA; Morales IR; Sankaran P; Berger AE; Deutsch JS; Zhu QC; Anders RA; Hooper JE; Pardoll DM; Lipson EJ; Taube JM; Topalian SL
    J Transl Med; 2024 Mar; 22(1):241. PubMed ID: 38443917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy.
    Dora D; Bokhari SMZ; Aloss K; Takacs P; Desnoix JZ; Szklenárik G; Hurley PD; Lohinai Z
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma.
    Wind TT; Gacesa R; Vich Vila A; de Haan JJ; Jalving M; Weersma RK; Hospers GAP
    Melanoma Res; 2020 Jun; 30(3):235-246. PubMed ID: 31990790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community characteristics of the gut microbiomes of competitive cyclists.
    Petersen LM; Bautista EJ; Nguyen H; Hanson BM; Chen L; Lek SH; Sodergren E; Weinstock GM
    Microbiome; 2017 Aug; 5(1):98. PubMed ID: 28797298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis.
    Galipeau HJ; Caminero A; Turpin W; Bermudez-Brito M; Santiago A; Libertucci J; Constante M; Raygoza Garay JA; Rueda G; Armstrong S; Clarizio A; Smith MI; Surette MG; Bercik P; ; Croitoru K; Verdu EF
    Gastroenterology; 2021 Apr; 160(5):1532-1545. PubMed ID: 33310084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients.
    Frankel AE; Coughlin LA; Kim J; Froehlich TW; Xie Y; Frenkel EP; Koh AY
    Neoplasia; 2017 Oct; 19(10):848-855. PubMed ID: 28923537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.
    Björk JR; Bolte LA; Maltez Thomas A; Lee KA; Rossi N; Wind TT; Smit LM; Armanini F; Asnicar F; Blanco-Miguez A; Board R; Calbet-Llopart N; Derosa L; Dhomen N; Brooks K; Harland M; Harries M; Lorigan P; Manghi P; Marais R; Newton-Bishop J; Nezi L; Pinto F; Potrony M; Puig S; Serra-Bellver P; Shaw HM; Tamburini S; Valpione S; Waldron L; Zitvogel L; Zolfo M; de Vries EGE; Nathan P; Fehrmann RSN; Spector TD; Bataille V; Segata N; Hospers GAP; Weersma RK
    Nat Med; 2024 Mar; 30(3):785-796. PubMed ID: 38365950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Assessment of Shotgun Metagenomics and 16S rDNA Amplicon Sequencing in the Study of Human Gut Microbiome.
    Laudadio I; Fulci V; Palone F; Stronati L; Cucchiara S; Carissimi C
    OMICS; 2018 Apr; 22(4):248-254. PubMed ID: 29652573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.